Pistacia atlantica Oleoresin of preparation on weight loss

Evaluation of the effect of Pistacia Atlantica Oleoresin of preparation on weight loss in women 18-60 years old with overweight and obesity (BMI=25), Double-blind randomized controlled clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221022056262N1

Enrollment

Registered

2022-12-09

Start date

2023-01-21

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

overweight and obesity. Obesity, unspecified

Interventions

Intervention 1: Intervention group: Daily consumption of two 500 mg capsules of Pistacia Atlantica Oleoresin, half an hour after breakfast and dinner for 8 weeks. Pistacia Atlantica Oleoresin capsules

Eligibility

Sex/Gender

Female

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Women with mild to moderate initial overweight and obesity(BMI 25-39.9)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The amount of weight change (body mass index) in overweight and obese women. Timepoint: Measurement of body mass index before the intervention, 30, 60, and 90 days after the start of the intervention. Method of measurement: Digital weighing machine.	—

Secondary

Measure	Time frame
Measurement of the size of the abdomen. Timepoint: At the beginning of the study (before the start of the intervention), 30, 60, and 90 days after the start of intervention. Method of measurement: Measuring meter.;Blood cholesterol, triglycerides, LDL and HDL levels. Timepoint: At the beginning of the study (before the start of the intervention) and 60 days after the start of the intervention. Method of measurement: blood test.;Measure the size of the hip circumference. Timepoint: At the beginning of the study (before the start of the intervention), 30, 60, and 90 days after the start of intervention. Method of measurement: Measuring meter.;Measurement of the ratio of the size of the abdominal circumference to the size of the hip circumference. Timepoint: At the beginning of the study (before the start of the intervention), 30, 60, and 90 days after the start of intervention. Method of measurement: Measuring meter.	—

Measure

Time frame

Measurement of the size of the abdomen. Timepoint: At the beginning of the study (before the start of the intervention), 30, 60, and 90 days after the start of intervention. Method of measurement: Measuring meter.;Blood cholesterol, triglycerides, LDL and HDL levels. Timepoint: At the beginning of the study (before the start of the intervention) and 60 days after the start of the intervention. Method of measurement: blood test.;Measure the size of the hip circumference. Timepoint: At the beginning of the study (before the start of the intervention), 30, 60, and 90 days after the start of intervention. Method of measurement: Measuring meter.;Measurement of the ratio of the size of the abdominal circumference to the size of the hip circumference. Timepoint: At the beginning of the study (before the start of the intervention), 30, 60, and 90 days after the start of intervention. Method of measurement: Measuring meter.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeid Mohseni

Babol University of Medical Sciences

saeidmohseny12463@gmail.com+98 11 3225 0824

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026